Jim Simons Protara Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 314,300 shares of TARA stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

314,300

Previous 149,200 110.66%

Holding current value

$1.73 Million

Previous $452,000 202.43%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.78 - $4.41 $458,977 - $728,091	165,100 Added 110.66%	314,300 $1.37 Million
Q2 2025 Aug 13, 2025	BUY	$2.88 - $4.42 $57,024 - $87,516	19,800 Added 15.3%	149,200 $452,000
Q1 2025 May 14, 2025	SELL	$3.37 - $6.14 $43,473 - $79,206	-12,900 Reduced 9.07%	129,400 $551,000
Q4 2024 Feb 13, 2025	SELL	$1.68 - $7.53 $326,659 - $1.46 Million	-194,440 Reduced 57.74%	142,300 $747,000
Q3 2024 Nov 13, 2024	BUY	$1.7 - $2.4 $316,778 - $447,216	186,340 Added 123.9%	336,740 $616,000

Q2 2024 Aug 09, 2024	BUY	$1.96 - $4.14 $128,968 - $272,412	65,800 Added 77.78%	150,400 $312,000
Q1 2024 May 13, 2024	SELL	$1.86 - $4.83 $53,382 - $138,621	-28,700 Reduced 25.33%	84,600 $339,000
Q4 2023 Feb 13, 2024	BUY	$1.12 - $1.93 $59,584 - $102,676	53,200 Added 88.52%	113,300 $212,000
Q3 2023 Nov 14, 2023	SELL	$1.64 - $2.93 $38,540 - $68,855	-23,500 Reduced 28.11%	60,100 $100,000
Q2 2023 Aug 11, 2023	BUY	$2.27 - $3.59 $56,055 - $88,651	24,694 Added 41.92%	83,600 $200,000
Q1 2023 May 12, 2023	SELL	$2.76 - $3.91 $22,339 - $31,647	-8,094 Reduced 12.08%	58,906 $184,000
Q4 2022 Feb 13, 2023	SELL	$2.43 - $3.7 $29,646 - $45,140	-12,200 Reduced 15.4%	67,000 $180,000
Q3 2022 Nov 14, 2022	BUY	$2.96 - $4.27 $74,000 - $106,749	25,000 Added 46.13%	79,200 $234,000
Q2 2022 Aug 12, 2022	BUY	$2.8 - $5.33 $46,480 - $88,478	16,600 Added 44.15%	54,200 $159,000
Q1 2022 May 13, 2022	SELL	$4.19 - $6.9 $113,968 - $187,680	-27,200 Reduced 41.98%	37,600 $192,000
Q4 2021 Feb 11, 2022	SELL	$6.15 - $7.76 $314,265 - $396,536	-51,100 Reduced 44.09%	64,800 $437,000
Q3 2021 Nov 12, 2021	BUY	$6.38 - $9.3 $411,337 - $599,598	64,473 Added 125.37%	115,900 $802,000
Q2 2021 Aug 13, 2021	BUY	$8.68 - $16.99 $173,834 - $340,258	20,027 Added 63.78%	51,427 $501,000
Q1 2021 May 13, 2021	BUY	$13.75 - $23.86 $196,487 - $340,959	14,290 Added 83.52%	31,400 $494,000
Q4 2020 Feb 10, 2021	SELL	$16.97 - $25.34 $350,871 - $523,929	-20,676 Reduced 54.72%	17,110 $414,000
Q3 2020 Nov 13, 2020	BUY	$16.76 - $31.89 $130,728 - $248,742	7,800 Added 26.01%	37,786 $636,000
Q2 2020 Aug 13, 2020	BUY	$22.0 - $60.7 $659,692 - $1.82 Million	29,986 New	29,986 $879,000

Others Institutions Holding TARA

# of Institutions

Shares Held

24.3M

Call Options Held

13K

Put Options Held

46.4K

View Full List

About Protara Therapeutics, Inc.

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $62.1M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

More about TARA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account